vocabulary: regeneron
description: Vocabulary for Regeneron Pharmaceuticals' therapeutic and research areas
terms:
  - term: EYLEA
    definition: Aflibercept anti-VEGF therapy for retinal diseases
  - term: EYLEA HD
    definition: High-dose aflibercept formulation for extended dosing intervals
  - term: Dupixent
    definition: Dupilumab IL-4/IL-13 monoclonal antibody co-developed with Sanofi
  - term: Libtayo
    definition: Cemiplimab anti-PD-1 monoclonal antibody for oncology
  - term: Lynozyfic
    definition: Linvoseltamab T-cell engager for multiple myeloma
  - term: Praluent
    definition: Alirocumab PCSK9 inhibitor for cardiovascular disease
  - term: Regeneron Genetics Center
    definition: Regeneron's large-scale exome sequencing and human genetics research arm
  - term: VelocImmune
    definition: Regeneron's proprietary platform for fully human antibody discovery
dimensions:
  - name: therapeutic-area
    values: [Ophthalmology, Immunology, Oncology, RareDisease, Cardiovascular, InfectiousDisease, Neurology]
  - name: modality
    values: [MonoclonalAntibody, TCellEngager, AntibodyCocktail, GeneTherapy]